Nova Biomedical develops and manufactures medical devices and diagnostics equipment that can be used by health-care providers for advanced blood testing and analysis, according to its website.
Concentra Group Holdings Parent, Inc. (NYSE: CON), a leader in occupational health services with a market capitalization of $2.84 billion, has announced preliminary financial results for the fourth ...
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CON stock, giving a Buy rating yesterday. Ann Hynes’s rating is based on Concentra Group Holdings Parent, Inc.’s ...